Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
December 3, 2001
- WORLD NEWS IN BRIEF
December 3, 2001
- Aiming at \2 Trillion Sales in FY2009: Kuraya Sanseido President
December 3, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 3, 2001
- Kissei Withdraws Additional Indication Application for Rizaben
December 3, 2001
- Nippon Roche, GSK/IPF Hold Seminars on Influenza
December 3, 2001
- Otsuka Signs Contract with Celera Genomics for Genomic Database
December 3, 2001
- OTC NEWS IN BRIEF
December 3, 2001
- Kyorin Beefs Up Globalization by Forming Subsidiary in Europe
December 3, 2001
- Semi-annual Sales of OTC Drugs Up 1.1% from Last Year: INTAGE Survey
December 3, 2001
- REGULATORY NEWS IN BRIEF
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
November 26, 2001
- OTC NEWS IN BRIEF
November 26, 2001
- Daiichi Considers Independent Marketing in Europe: President Morita
November 26, 2001
- Top 10 Companies Report Bullish Interim Results
November 26, 2001
- MPC to Complete Marketing Line Integration by March
November 26, 2001
- Toru Nagashima Appointed New President at Teijin
November 26, 2001
- BUSINESS NEWS IN BRIEF
November 26, 2001
- Remicade, Simulect Designated as Orphans
November 26, 2001
- Pressure on Medical Fees Gains Momentum
November 26, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…